Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . June 14th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Autoimmune Disease - Diagnoses of zone 3 hepatitis-related autoimmune hepatitis avert cirrhosis
Dialysis - Hemofiltration may trap and destroy hepatitis C virus particles
Drug Detection - Liquid chromatography-tandem mass spectrometry measures PMEA in human sera
Hepatitis C Virus Therapy - Interactions between HCV NS5A protein and 2-tAS counteract interferon
Infectious Disease - Hepatitis E virus causes non-A, non-B, non-C acute hepatitis in Japan
Angiology - Increased vascular HO-1 expression contributes to vasodilation in cirrhotic rats
Apoptosis - Cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells
Business Update - New company launched for development of therapeutic DNA vaccines
Cancer Risk Factor - Heavy drinkers are vulnerable to liver cancer despite negative viral hepatitis
Endocrinology - Steatohepatitis signals insulin resistance during growth hormone therapy
Enzymology - Anti-GM3 synthase antibody enables immunodetection in human tissue
Enzymology - New protein constructs stymie hepatitis D virus RNA editing
Gastroenterology - Autophagy and enzyme activation link alpha1 -AT-deficiency to liver disease
Genetic Marker - CCR5Delta32 polymorphism a risk factor for ischemic-type biliary lesions
Genomics - ACAT-1 transcripts predominate in liver and ACAT-2 predominate in the duodenum
Hepatitis - New preclinical results show prevention of liver injury by histamine
Hepatitis - Publication highlights antiviral activity of NEUGENE antisense compound
Hepatitis - Viramidine 24-week data presented from chronic hepatitis C phase II trials
Hepatitis B Virus - Spread of hepatitis B viruses in vitro requires extracellular progeny
Hepatitis C - 1,000 patients enrolled in phase III hepatitis C trials evaluating Zadaxin
Hepatitis C - Study: Nearly 30% of hepatitis C treatment candidates not receiving therapy
Hepatitis C - Trial data of hepatitis C patients after liver transplantation presented
Hepatitis C - Trial results for NM283 for the treatment of HCV reported
Hepatitis C Vaccine - Hepatitis C-derived lipopeptides induced antibody-producing T cells
Hepatology - Anti-GST autoantibody could be an early marker of autoimmune hepatitis
Immunology - Virus-specific regulatory T cells counteract anti-hepatitis C virus response
Liver Cancer - Hepatocellular carcinoma regresses spontaneously in some instances
Liver Transplantation - Numerical simulation model of hypothermic machine perfusion effective
Liver Tumors - Portal vein embolization can increase the safety of hepatic resection
Mergers and Acquisitions - Hepatitis drug maker acquired
Proteomics - The N-terminal region of hepatitis C virus core protein generates nucleocapsids
Stem Cell Research - Self-renewal capacity is a widespread property of neural crest precursor cells
Transplant Medicine - Adult living donor liver transplantations have been slow to gain acceptance
Transplant Medicine - Study may improve survival of transplanted livers
Transplantation Medicine - LEA29Y may provide new option for preventing organ rejection
Viral Assembly - Lysine 72 acetylation influences hepatitis delta virus RNA synthesis
Virology - Hepadnavirus assembly diminishes with impaired protein glycosylation
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
